Search Results

SGLT2 inhibitors are a type of medication used to treat heart failure and diabetes. The only SGLT2 inhibitor available in New Zealand is empagliflozin. Learn about how empagliflozin works, its benefits and side effects.

Found in Medication

ARNIs are a type of medication used to treat heart failure. Currently the only ARNI available in New Zealand is Entresto (valsartan/sacubitril). Learn how Entresto works and about its side effects.

Found in Medication

Beta blockers steady your heart rate and rhythm, lower your blood pressure and reduce the risk of you having a heart attack. Read about the types of beta blockers, how they work and their possible side effects.

Found in Medication

ACE inhibitors (angiotensin-converting enzyme inhibitors) are medications that lower blood pressure and lessen the workload of your heart. Read about the different types of ACE inhibitors, how they work, and their side effects.

Found in Medication

Angiotensin II Receptor Blockers (ARBs) help relax your veins and arteries to lower your blood pressure, making it easier for your heart to pump. Read about the different types of ARBs, how they work, and their side effects.

Found in Medication

New research with the aim of improving heart health for Māori is among a number of research grants awarded by the Heart Foundation announced today.

Found in Articles

A pacemaker that mimics the hearts of elite athletes, a simple blood test to predict imminent heart attacks, and ‘living drugs’ to regenerate damaged heart tissue, are just three of a host of research projects awarded funding, the Heart Foundation announced today.

Found in Articles

Thousands of New Zealanders can look forward to improvements in treatment and care of heart failure following new research findings that look set to alter the clinical approach and health care planning for heart failure globally.

Found in Articles

Leading cardiologists and the Heart Foundation are calling for all New Zealanders with heart failure to have access to the latest healthcare and medications for optimal management of heart failure. This would bring New Zealand into line with international best practice.

Found in Articles

A researcher at the forefront of cardiac energetics globally, Dr JC Han at the University of Auckland, has been awarded a Senior Fellowship from the Heart Foundation to investigate improving heart efficiency.

Found in Articles

A New Zealand study will explore whether gut bacteria can predict heart failure risk after a heart attack, potentially leading to earlier diagnosis, personalised treatment, and new ways to protect heart health.

Found in Articles

A revolutionary pacemaker, developed at the University of Auckland, is giving new hope to the 80,000 people living with heart failure in New Zealand, thanks to funding from several organisations, including the Heart Foundation.

Found in Articles